Log In
Print
BCIQ
Print
Print this Print this
 

Recombinant human acid ceramidase (rhAC)

  Manage Alerts
Collapse Summary General Information
Company Plexcera Therapeutics LLC
DescriptionRecombinant human acid ceramidase (rhAC)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationLipodystrophy
Indication DetailsTreat Faber disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today